Drugs / 68Ga-XT771
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07067905 | Jun 2025 → Apr 2026 overdue | — | Chinese PLA General Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-XT771 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07067905 ↗ |
| Modality | Diagnostic / imaging agent | “diagnostic value of 68Ga-XT771, a CAIX/CAXII protein-specific probe, in PET/CT imaging” NCT07067905 ↗ |
| Route | Intravenous | “68Ga-XT771 is injected intravenously” NCT07067905 ↗ |